id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id FDA-2009-D-0533-0001,FDA,FDA-2009-D-0533,"Draft Guidance for Industry: Recommendations for the Assessment of Blood Donor Suitability, Blood Product Safety, and Preservation of the Blood Supply in Response to Pandemic (H1N1) 2009 Virus; Availability",Notice,NAD-Notice of Availability of Data,2009-11-19T05:00:00Z,2009,11,2009-11-19T05:00:00Z,2009-12-04T04:59:59Z,2009-11-19T15:09:58Z,E9-27729,0,0,0900006480a5ab15 FDA-2009-D-0533-0002,FDA,FDA-2009-D-0533,Guidance for Industry Recommendations for the Assessment of Blood Donor Suiability,Other,GDL-Guidance (Supporting and Related Materials),2009-11-19T05:00:00Z,2009,11,2009-11-19T05:00:00Z,,2024-11-12T04:49:08Z,,1,0,0900006480a5abb8